Skip to main content
Show — Main navigation
Hide — Main navigation
Hair & Scalp
Expert Insights in Derm
Resident Journal Club Blog
Centers of Excellence
AAD Summer Meeting
SDPA Fall Conference
AAD VMX 2020
Music City SCALE
Centers of Excellence
Hidradenitis Suppurativa News
HS Diagnosis Can Take Up to 10 Years
Findings from a recent study showed patients with hidradenitis suppurativa experienced significant delays in receiving a diagnosis, and these delays were associated with more severe disease burden.
Adalimumab Is Effective In Real-World Setting
A recent poster study, presented at AAD VMX 2020, showed that adalimumab effectively reduced hidradenitis suppurativa activity among patients at an outpatient dermatology center.
Major Depressive Disorder Increases Risk of Autoimmune Skin Diseases
Findings from a recent study showed major depressive disorder was associated with an increased risk of autoimmune skin diseases, including hidradenitis suppurativa.
HS Disease Trajectory Includes Several Comorbidities
Findings from a recent study indicated that several comorbidities precede a diagnosis of hidradenitis suppurativa, and that several develop afterwards.
Biologic May be Effective for Patients With HS
Findings from an open label cohort study showed treatment of moderate to severe hidradenitis suppurativa with an IL-17 inhibitor was associated clinical response and had a favorable safety profile.
Risk of HS in Adulthood Associated with Childhood Weight
Findings from a recent study showed a potential association between birth weight and childhood weight and the risk of developing hidradenitis suppurativa in adulthood.
Almost 10% of HS Patients Have Comorbid Inflammatory Eye Disease
In a recent study, researchers assessed the prevalence of inflammatory eye disease and treatment outcomes among patients with hidradenitis suppurativa.
Recurrent Rates Higher With Partial Excision for HS
A recent systemic review showed patients with hidradenitis suppurativa who underwent partial excision had higher recurrence rates compared with wide excision.
About One-third of HS Patients Receive Appropriate Weight Counseling
A recent study showed only 32% of patients with hidradenitis suppurativa who are overweight or obese receive weight counseling, which suggests more awareness and education about weight management and nutrition among this patient population.
Does Delaying Adalimumab Affect Treatment Response?
A recent study identified a possible ‘window of opportunity’ for initiating adalimumab that could predict treatment response among patients with hidradenitis suppurativa.
Stay in the know.
The Dermatologist Newsletter
Back to Top